1 In the REIMAGINE 2 trial, the most commonly reported AEs were GI-related, occurring in 405/603 (67.2%) participants in the CagriSema 2.4 mg/2.4 mg group, 326/605 (53.9%) participants in the semaglutide 2.4 mg group, 60/152 (39.5%) participants in the cagrilintide 2.4 mg group, 329/594 (55.4%) participants in the CagriSema 1 mg/1 mg group, 288/608 (47.4%) participants in the semaglutide 1 mg group, and 42/149 (28.2%) participants in the placebo group
References Sosne G, Qiu P, Kurpakus-Wheater M
Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts
The molecular mechanism involves Epitalon binding to chromatin regulatory regions upstream of the TERT promoter evidenced by altered histone acetylation (H3K9ac +1.3 in aged lymphocyte culture) and TERT mRNA upregulation +1.41.6 measured by RT-PCR in aged (1822-month) C57BL/6J tissue homogenates (hippocampus, bone marrow, intestinal epithelium)
This 50mg vial provides research-grade GHK-Cu for laboratory investigation of dermal biology, wound healing mechanisms, and copper-dependent peptide signalling
Reconstitution Most peptides are available as lyophilized powders and must be reconstituted with a sterile solvent to be injected